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Elevating care through discovery
Implementation of Stroke Pathways to Reduce Length of Stay, Cost, 
Readmissions, and Mortality
Jayme Strauss, RN, MSN, MBA, SCRN, Daniel Hartnett, RN, MSN, SCRN, Jenny Ductant, RN, MSN, Peter De Armas, RN, BSN, 
Albert Fernandez, RN, BSN, SCRN, Andrew Waisbrot, RN, BSN, Amy K. Starosciak, Ph.D., Felipe De Los Rios La Rosa, M.D .
OBJECTIVE
To reduce length of stay (LOS) and variable cost per
case for stroke cases on a Neuroscience unit in a
community Comprehensive Stroke Center using
standardized, evidence-based clinical pathways.
BACKGROUND
Acute stroke is a major contributor to healthcare costs. In
2012, estimated direct costs associated with stroke were
$71B, which is projected to double to $184B by 2030. As
healthcare evolves and reimbursements decrease, cost
control is critical. In January 2017, LOS, variable and
total cost/case peaked at our hospital at 5.25 days,
$7.8K and $18K, respectively. In fiscal year 2017 the 30-
d readmission rate was 9% and the mortality rate was
12%. Compliance with stroke admission order sets was
at 55%.
METHODS
A multidisciplinary committee was formed in 02/2017 to
develop standardized, evidence-based clinical pathways
for three populations:
• Ischemic stroke (IS) treated with IV t-PA
• TIA/IS without IV t-PA
• Intracerebral hemorrhage
The team met biweekly to standardize clinical pathways,
decrease time to follow-up imaging, focus on physician
order set utilization, and control costs. A comprehensive
education program was rolled out and implementation of
the pathways was in 11/2017. Pathways are discussed
daily in stroke and rapid discharge rounds to ensure
compliance and identify opportunities for improvement.
RESULTS
We reviewed a retrospective financial report of all in-
hospital cases coded as MS-DRG 61-69 from 12/2017
through 12/2018 and compared it the 1/2017 report for
adjusted LOS (ALOS) (Fig. 1), case mix index (CMI)
(Fig. 2), variable and total costs per case (Fig.3),
readmissions (Fig.4), and mortality (Fig. 5).
Figure 3. Total (A) and Variable (B) cost/case per 
month and by fiscal year
RESULTS
• ALOS and variable and total costs per case increased 
starting in June 2018
• Mimicked CMI increase which started in June 2018
• Readmission and mortality rates decreased since 
January 2017, and then increased slightly since 
implementation in November 2017
• Order set compliance was 91% as of June 2018, but 
dropped to 87% by December 2018
CONCLUSIONS
• Standardization of stroke clinical pathways may lead
to reductions in variable and total costs per case, and
shorten length of stay without increasing mortality or
readmission rate, however the effect was not
sustained.
• This result may be because of increased CMI or a
drop in order set compliance rates. Further analyses
are required.
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Figure 1. Monthly and 
fiscal year ALOS 
Figure 2. Monthly and 
fiscal year CMI
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Figure 4. Quarterly 
and fiscal year 
readmission rate 
Figure 5. Quarterly 
and fiscal year 
mortality rate 
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